|
|
03 Aug 2011
PHARMACEUTICAL DEVELOPMENT business Vernalis has appointed chartered accountant Nigel Sheail as a non-executive director.
Sheail learned his trade at Ernst & Young, before joining Glaxo.
He has spent much of his career at Hoffman-La Roche, where he has worked in a number of corporate finance and licensing roles in China, the US and Switzerland.
"His depth of experience in the global pharmaceutical industry will be very valuable for the Board, and we look forward to his contribution, as we seek to build future value for Vernalis shareholders," said Vernalis chairman Peter Fellner.
For more companies and markets data visit the Share Price Centre
You may also like
Search thousands of financial jobs:
Search thousands of financial jobs:
Careers
Search for jobs
Click to search our database of all the latest accountancy roles
Create a profile
Click to set up your profile and let the best recruiters find you
Jobs by email
Sign up to receive regular updates with the latest roles suitable for you
Briefings
By looking at the reasons supplier statements became unfashionable, and the reasons why it is different today, this paper delves into the many benefits that can be obtained by automating the process.
Having a real and true view of your organisation’s current financial position, and having the right systems and processes in place, will ensure that you can make strong choices and are ready to capitalise on opportunities
AccountancyAgeInsight is a frequently updated resource centre for finance professionals, offering a free and easy-to-use digital library of briefings, white papers and other information resources. 
Visitor comments Add your comment